Literature DB >> 11504305

Risk factors for male breast cancer--a case-control study from Scandinavia.

M Ewertz1, L Holmberg, S Tretli, B V Pedersen, A Kristensen.   

Abstract

We report a population-based case-control study on risk factors for male breast cancer. Data on a broad range of previously suggested risk factors were collected in a set of Scandinavian breast cancer cases and matched controls. Incident cases (n = 282) with histologically verified carcinomas of the breast were identified from notification to the cancer registries of Denmark, Norway and Sweden over a 4-year period 1987-1991 and of these cases, 156 men could be approached and responded. Controls were identified through national central population registers and were matched individually for country, sex and year of birth. Controls with a diagnosis of breast cancer were excluded; 468 of 780 controls responded. Data on risk factors were collected by self-administered questionnaires mailed to the cases between land 2 years after diagnosis and to controls during the same period. The findings were compatible with an increased risk associated with family history of breast cancer (odds ratio (OR) = 3.3, 95% confidence interval (CI) 2.0-5.6), obesity 10 years before diagnosis (OR = 2.1, 95% CI 1.0-4.5) for BMI > 30, diabetes (OR = 2.6, 95% CI 1.3-5.3) and the use of digoxin and methyldopa (OR = 2.0 and 2.1, respectively). The association with family history of breast cancer has been repeated in several studies, while the relation to anthropometric measures has been equivocal. We could not substantiate some associations seen in other studies; namely those with high education, fertility, marital status, testicular injury, liver disease and religion. The detailed questions about gynaecomastia indicated that many cases reported signs of breast cancer as a gynaecomastia. This type of misunderstanding may explain the strong association with gynaecomastia seen in other studies. Several patients died before contact. Thus, risk factors related to a more aggressive male breast cancer or related to high risk of dying (e.g. liver cirrhosis, heavy smoking) may have been missed.

Entities:  

Mesh:

Year:  2001        PMID: 11504305     DOI: 10.1080/028418601750288181

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  48 in total

1.  A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.

Authors:  Elizabeth A Platz; Srinivasan Yegnasubramanian; Jun O Liu; Curtis R Chong; Joong Sup Shim; Stacey A Kenfield; Meir J Stampfer; Walter C Willett; Edward Giovannucci; William G Nelson
Journal:  Cancer Discov       Date:  2011-06       Impact factor: 39.397

2.  [Bizarrely patterned erythema and papules in a 39-year-old man. Lymphangiosis carcinomatosa as the chief symptom of disseminated metastatic breast carcinoma in a man].

Authors:  S Emmert; H P Bertsch; M Zutt; H Haenssle; C Hallermann; L Kretschmer; Ch Neumann
Journal:  Hautarzt       Date:  2002-07       Impact factor: 0.751

Review 3.  Male Breast Cancer.

Authors:  Metin Yalaza; Aydın İnan; Mikdat Bozer
Journal:  J Breast Health       Date:  2016-01-01

Review 4.  The Epidemiology of Male Breast Cancer.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Curr Oncol Rep       Date:  2016-01       Impact factor: 5.075

5.  Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk.

Authors:  Louise A Brinton; Tim J Key; Laurence N Kolonel; Karin B Michels; Howard D Sesso; Giske Ursin; Stephen K Van Den Eeden; Shannon N Wood; Roni T Falk; Dominick Parisi; Chantal Guillemette; Patrick Caron; Véronique Turcotte; Laurel A Habel; Claudine J Isaacs; Elio Riboli; Elisabete Weiderpass; Michael B Cook
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

6.  Therapeutic efficacy of 188Re-liposome in a C26 murine colon carcinoma solid tumor model.

Authors:  Ya-Jen Chang; Chin-Wei Hsu; Chih-Hsien Chang; Keng-Li Lan; Gann Ting; Te-Wei Lee
Journal:  Invest New Drugs       Date:  2012-12-09       Impact factor: 3.850

7.  Male breast cancer - a single center experience.

Authors:  Branislav Bystricky; Filip Kohutek; Andrej Rosik
Journal:  Oncol Lett       Date:  2016-06-30       Impact factor: 2.967

8.  Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis.

Authors:  Thomas P Ahern; Rulla M Tamimi; Bernard A Rosner; Susan E Hankinson
Journal:  Breast Cancer Res Treat       Date:  2014-02-28       Impact factor: 4.872

Review 9.  HER2-positive male breast cancer: an update.

Authors:  Laura Ottini; Carlo Capalbo; Piera Rizzolo; Valentina Silvestri; Giuseppe Bronte; Sergio Rizzo; Antonio Russo
Journal:  Breast Cancer (Dove Med Press)       Date:  2010-10-04

10.  Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.

Authors:  Andrea Perne; Markus K Muellner; Magdalena Steinrueck; Nils Craig-Mueller; Julia Mayerhofer; Ilse Schwarzinger; Mathew Sloane; Iris Z Uras; Gregor Hoermann; Sebastian M B Nijman; Matthias Mayerhofer
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.